Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibitionIrene Caffa(Ospedale Policlinico San Martino), Alessio Nencioni(Ospedale Policlinico San Martino)OncotargetMarch 18, 201510.18632/oncotarget.3689Cited by 91SaveCiteExport RISWatch citationsRelated PapersFasting-mimicking diet and hormone therapy induce breast cancer regression|Nature|2020|361Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation|Blood|2006|132Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair|Cancer Research|2017|108Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells|PLoS ONE|2011|86Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice|Thrombosis and Haemostasis|2013|50